300146.SZ SHZ
By-health Co., Ltd.
1W: +0.0%
1M: -3.8%
3M: +1.2%
YTD: -24.4%
1Y: -20.9%
3Y: -50.0%
5Y: -64.0%
¥9.43 ($1.41)
+0.14 (+1.51%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.4B
+100.8% ▲
5Y CAGR: -2.5%
Capital Expenditures
$133M
+56.4% ▲
5Y CAGR: -16.1%
Free Cash Flow
$1.2B
+227.2% ▲
5Y CAGR: -0.0%
Dividends Paid
$606M
+60.0% ▲
Buybacks
$105M
+56.5% ▲
Net Change in Cash
-$148M
+79.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.8B | $1.4B | $1.8B | $648M | $782M |
| Depreciation & Amort. | $246M | $244M | $248M | $262M | $290M |
| Stock-Based Comp. | -$7M | -$38M | $0 | $0 | $0 |
| Change in Working Capital | -$30M | -$261M | $199M | -$290M | $152M |
| Other Non-Cash Items | -$153M | $86M | -$174M | $66M | $181M |
| Operating Cash Flow | $1.8B | $1.4B | $2.1B | $686M | $1.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$263M | -$245M | -$1.3B | -$306M | -$133M |
| Acquisitions (Net) | $267M | $3M | $706K | -$924M | $58M |
| Investment Purchases | -$4.2B | -$6.1B | -$6.0B | -$7.5B | -$8.8B |
| Investment Sales | $2.1B | $6.2B | $6.0B | $7.5B | $7.9B |
| Other Investing | -$263M | -$1000K | -$141M | $50M | $0 |
| Investing Cash Flow | -$2.4B | -$131M | -$1.4B | -$1.1B | -$895M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$246M | $0 | $0 | $1.5B | -$524M |
| Stock Repurchased | $1M | $0 | -$18M | -$242M | -$105M |
| Dividends Paid | -$1.1B | -$1.2B | -$306M | -$1.5B | -$606M |
| Other Financing | $3.0B | -$37M | -$66M | -$42M | -$2M |
| Financing Cash Flow | $1.6B | -$1.2B | -$372M | -$263M | -$1.2B |
| Net Change in Cash | $1.1B | $58M | $365M | -$732M | -$148M |
| Cash End of Period | $2.9B | $3.0B | $3.3B | $2.6B | $2.4B |
| Free Cash Flow | $1.6B | $1.1B | $794M | $380M | $1.2B |